EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

…, P Bacon, JW Cohen-Tervaert, L Guillevin… - Annals of the …, 2007 - ard.bmj.com
Objectives: To develop the European League Against Rheumatism (EULAR) recommendations
for conducting clinical studies and/or clinical trials in systemic vasculitis. Methods: An …

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic …

…, JW Cohen-Tervaert, WL Gross, L Guillevin… - Annals of the …, 2008 - ard.bmj.com
Objectives: We undertook a systematic literature review as a background to the European
League Against Rheumatism (EULAR) recommendations for conducting clinical trials in anti-…

Reactive hemophagocytic syndrome in adult systemic disease: report of twenty‐six cases and literature review

…, A Schaeffer, JC Piette, L Guillevin… - Arthritis Care & …, 2003 - Wiley Online Library
Objective. To analyze specific clinical findings, underlying disorders, treatments, outcomes,
and prognostic factors for reactive hemophagocytic syndrome (RHS) in systemic disease. …

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist

…, J Molitor, JR Seibold, V Hsu, L Guillevin… - Arthritis & …, 2004 - Wiley Online Library
Objective Recurrent digital ulcers are a manifestation of vascular disease in patients with
systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We …

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

…, D Abramowicz, F Ferrario, L Guillevin… - Journal of the …, 2007 - journals.lww.com
… When compared with a study from this group of vasculitis with serum creatinine <500 μmol/L
(5.8 mg/dl), patients in this study were older (mean 64.3 versus 55.6 yr; P < 0.0001). They …

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome a prospective study in 342 patients

L Guillevin, F Lhote, M Gayraud, P Cohen, B Jarrousse… - Medicine, 1996 - journals.lww.com
… Gayraud M, Le Clercq P, Guillevin L. Treatment of good prognosis polyarteritis nodosa and
Guillevin L, Lhote F. Distinguishing polyarteritis nodosa from microscopic polyangiitis and …

[HTML][HTML] Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis

L Guillevin, C Pagnoux, A Karras… - … England Journal of …, 2014 - Mass Medical Soc
Background The combination of cyclophosphamide and glucocorticoids leads to remission
in most patients with antineutrophil cytoplasm antibody (ANCA)–associated vasculitides. …

[HTML][HTML] Genetically distinct subsets within ANCA-associated vasculitis

…, L Guillevin, I Gunnarsson, L Harper… - … England Journal of …, 2012 - Mass Medical Soc
Background Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a severe
condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly …

Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study

E Hachulla, V Gressin, L Guillevin… - Arthritis & …, 2005 - Wiley Online Library
Objective Screening allows for early management of pulmonary arterial hypertension (PAH),
a severe complication of systemic sclerosis (SSc). Since no consensus has been reached …

Churg-Strauss syndrome clinical study and long-term follow-up of 96 patients

L Guillevin, P Cohen, M Gayraud, F Lhote, B Jarrousse… - Medicine, 1999 - journals.lww.com
… Mean serum creatinine for these patients was 120 t 50 pumol/L, while it was 82,2 t 31.6
pumol/L for the other 71 patients (p < 0.01); 5 (5.2%) patients developed mild renal insufficiency …